Table 2 Differentially expressed lipids between AD patients with and without severe OSA
From: Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
Mass | RT (min) | Mass/z | Putative identity | Class | Fold change | p |
|---|---|---|---|---|---|---|
609.5135 | 8.21 | 608.5135 | OxCer(40:6) | Sphingolipid | 1.896 | 0.038 |
633.5593 | 8.21 | 632.5593 | Unknown | 2.343 | 0.016 | |
619.5427 | 8.21 | 618.5427 | Unknown | 1.925 | 0.016 | |
1168.376 | 9.83 | 1169.376 | Unknown | 0.799 | 0.027 | |
1201.37 | 9.96 | 1202.37 | Unknown | 0.679 | 0.006 | |
977.8707 | 10.24 | 978.8707 | OxTG(57:2) | Glycerolipid | 0.744 | 0.012 |
1994.984 | 10.74 | 1995.984 | Unknown | 1.281 | 0.009 | |
1134.433 | 7.44 | 1135.433 | Unknown | 0.519 | 0.028 | |
724.2482 | 8.42 | 725.2482 | Unknown | 0.708 | 0.041 | |
545.4296 | 5.1 | 546.4296 | Unknown | 1.277 | 0.042 | |
1571.475 | 10.43 | 1572.475 | Unknown | 1.384 | 0.049 |